YTS105 / BriSTAR Immunotech 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
YTS105 / BriSTAR Immunotech
NCT05344976: MSLN STAR-T Cells in the Treatment of Advanced Malignant Solid Tumors

Not yet recruiting
1
12
NA
MSLN STAR-T cells
Peking University
10/24
02/26

Download Options